Zobrazeno 1 - 10
of 14
pro vyhledávání: '"J. L. Balwierczak"'
Publikováno v:
Journal of Cardiovascular Pharmacology. 26:S393-396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b2be02b0a8c586221d2b9c9052e630b
https://doi.org/10.1097/00005344-199526003-00116
https://doi.org/10.1097/00005344-199526003-00116
Autor:
A J, Trapani, J L, Balwierczak, R W, Lappe, J L, Stanton, S C, Graybill, M F, Hopkins, P, Savage, D M, Sperbeck, A Y, Jeng
Publikováno v:
Biochemistry and molecular biology international. 31(5)
The IC50 values of phosphoramidon, CGS 25015, CGS 26129, thiorphan and benazeprilat for inhibition of endothelin converting enzyme partially purified from porcine aortic endothelial cells were 3.5, 18, 58,100 and100 microM, respectively. A similar ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6de7a89d81673f13f68730671c7f9c52
https://pubmed.ncbi.nlm.nih.gov/8136704
https://pubmed.ncbi.nlm.nih.gov/8136704
Publikováno v:
Biochemistry international. 27(6)
Endothelin-1 (ET-1) caused a dose-dependent contraction of porcine coronary arterial rings. Preincubation of ET-1 in oxygenated Krebs solution at 37 degrees C resulted in a progressive loss of the contractile activity and immunoreactivity of ET-1. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1b9fdc80ab33fad48b4917a8fd062aec
https://pubmed.ncbi.nlm.nih.gov/1445378
https://pubmed.ncbi.nlm.nih.gov/1445378
Publikováno v:
Biochemistry international. 22(4)
Inhibition of [125I]endothelin-1 ([125I]ET-1) binding to membrane fractions from various rat tissues by ET-1 and endothelin-3 (ET-3) was investigated. Brain tissue demonstrated a 37-fold higher affinity for ET-1 compared to lung, while a greater than
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68ddb5388292e38102f2010de72d527f
https://pubmed.ncbi.nlm.nih.gov/2078195
https://pubmed.ncbi.nlm.nih.gov/2078195
Publikováno v:
Molecular pharmacology. 31(2)
[3H]-d-cis-Diltiazem binds to canine cardiac sarcolemma in a specific, saturable, and reversible manner with a KD = 58.0 +/- 9.5 nM and a receptor site density (maximum binding) of 2.19 +/- 0.24 pmol/mg of protein. Bepridil and verapamil, Ca2+ channe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6333c9c7a09459eb0f10784892467fd7
https://pubmed.ncbi.nlm.nih.gov/2433570
https://pubmed.ncbi.nlm.nih.gov/2433570
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 251(1)
A series of adenosine A2 receptor agonists were examined for their ability to activate adenosine A2 receptors and inhibit nucleoside transport. A2 receptor activation was measured by the ability of these adenosine agonists to relax porcine coronary s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5afe80e8e33d07691465e59aef9ec78d
https://pubmed.ncbi.nlm.nih.gov/2795461
https://pubmed.ncbi.nlm.nih.gov/2795461
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 237(1)
[3H]Nitrendipine binds to canine cardiac sarcolemma in a specific, saturable and rapid manner. Bepridil, a Ca++ channel inhibitor, stimulates this binding at submicromolar concentrations, but inhibits it noncompetitively at higher concentrations (IC5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::16598b761798682d81374ce98b48d3d5
https://pubmed.ncbi.nlm.nih.gov/2937911
https://pubmed.ncbi.nlm.nih.gov/2937911
Autor:
Xiang, Hong-Jun (AUTHOR), Chai, Fu-Lu (AUTHOR), Wang, De-Sheng (AUTHOR), Dou, Ke-Feng (AUTHOR)
Publikováno v:
ISRN Oncology. 2011, p1-7. 7p.
Publikováno v:
ISRN Oncology. 2011, p1-7. 7p.
Publikováno v:
American Journal of Physiology: Heart & Circulatory Physiology; 1991, Vol. 260 Issue 5, pH1655-H1666, 12p